Results 1 to 3 of 3

MDM question

  1. #1
    Location
    Cactus Wren
    Posts
    14
    Question MDM question
    Exam Training Packages
    Does anyone out there have any experience with using drugs that need intensive monitoring to support a high level of risk in the risk portion of MDM. For example, coumadin is a drug that my physicians have identified as one that needs intensive monitoring. Would you always choose "high risk" in the MDM when a patient comes in who is on coumadin and the your physician is the one monitoring it?

    Kim

  2. #2
    Default
    I would think this would be Moderate "Prescription drug management"

    yvette

  3. Default
    I agree with yvette31. The drug itself needs intensive monitoring and may be considered a "high risk". But the medical decision making itself is not high risk.

    Under intensive monitoring it mentions toxicity. Guidelines under MDM for E/M levels:
    DG: High risk of MDM: "Drug therapy requiring intensive monitoring for toxicity"

    My understanding of Coumadin is:
    The objective of treatment with a blood-thinner is to control the blood-clotting process without causing severe bleeding, so that a clot does not form and cut off the blood supply necessary for normal body function. Therefore, it is very important that you take Coumadin exactly as prescribed by your doctor and that your doctor monitor your condition on a regular basis.

    My question is, is there a toxicity risk? I see the need to monitor but don't see the toxicity risk. I could be looking at wrong but the definition of toxicity is 1. the degree to which something is poisonous & 2. grave harmfulness or deadliness .

    Hope this helps. I used to code for pain management where there were drugs prescribed that were high risk (prescriptions and medication for pain pumps) and we never used high risk for MDM. The way it was described to me is the way I stated it at the top, the drug is High Risk, but the MDM is not.


    Quote Originally Posted by khaspert View Post
    Does anyone out there have any experience with using drugs that need intensive monitoring to support a high level of risk in the risk portion of MDM. For example, coumadin is a drug that my physicians have identified as one that needs intensive monitoring. Would you always choose "high risk" in the MDM when a patient comes in who is on coumadin and the your physician is the one monitoring it?

    Kim

Similar Threads

  1. MDM question
    By julia9723 in forum Auditing General Discussion
    Replies: 3
    Last Post: 11-18-2011, 03:01 PM
  2. another mdm question
    By anggand@aol.com in forum E/M
    Replies: 3
    Last Post: 10-14-2011, 07:36 PM
  3. Question about MDM?
    By asasands in forum E/M
    Replies: 4
    Last Post: 10-04-2011, 03:52 PM
  4. MDM question
    By jod867 in forum E/M
    Replies: 2
    Last Post: 05-27-2011, 11:00 AM
  5. question on MDM
    By mrolf in forum E/M
    Replies: 1
    Last Post: 08-01-2010, 01:03 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
Enjoying Our Forums?

AAPC forums are a benefit of membership. Joining AAPC grants you unlimited access, allowing you to post questions and participate with our community of over 150,000 professionals.

Join Now Continue Reading Without Full Access

Already a Member?

Login

Close Message

In addition to full participation on AAPC forums, as a member you will be able to:

  • Access to the largest healthcare job database in the world.
  • Join over 150,000 members of the healthcare network in the world.
  • Be a part of an industry leading organization that drives the business side of healthcare.
  • Save anywhere from 10%-50% with exclusive member discounts on courses, books, study materials, and conferences.
  • Access to discounts at hundreds of restaurants, travel destinations, retail stores, and service providers. AAPC members also have opportunities to save on heath, life, and liability insurance.
  • Become a member of a local chapter and attend regular meetings.